← SynDRA
BAVISANT
SynDRA canonical compound SYN0030062 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | HRH3 |
|---|
| Mechanism of action | Histamine receptor antagonist |
|---|
All known targets
Mechanisms of action (all sources)
- Histamine receptor antagonist
- HRH3 ANTAGONIST
- Histamine H3 receptor antagonist
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ADORA1
- HTR1A
- HTR3A
- HTR5A
- HTR6
- HTR7
- KCNH2
- MC4R
- NPY1R
- NPY2R
- OPRD1
- OPRL1
- OPRM1
- SLC6A2
- SLC6A3
- TACR2
- TACR3
- HTR2A
- HRH2
- ADORA2A
- HRH1
- ADORA3
- ADRB1
- AGTR1
- AVPR1A
- BDKRB2
- CCKAR
- CCR1
- CHRM1
- CHRM2
- CHRM3
- CXCR2
- DRD1
- EDNRA
- GALR2
- HDAC6
- VIPR1
Cross-references
Synonyms
- JNJ-31001074
- bavisantum
- RefChem:916750
- DTXCID70207943
- UNII-9827P7LFVH
- Bavisant [USAN:INN]
- Bavisant [USAN]
- Bavisant (USAN/INN)
- BAVISANT [INN]
- BAVISANT [WHO-DD]
- SCHEMBL522603
- orb1296246
- BGBVSGSIXIIREO-UHFFFAOYSA-N
- EMB62208
- BDBM50089371
- BDBM50138125
- EX-A10460
- MFCD19443732
- CS-1457
- EBC-8040892
- HY-14880
- TS-10641
- DB-110687
- NS00072138
- D09870
- G92152
- BRD-K79595931-312-01-3
- MFCD26142923
- MS-27373
- bavisant dihydrochloride hydrate
- UNII-1B5560RN9F
- D09871
- DA-71301
- Bavisant dihydrochloride anhydrous
- Bavisant 2HCl hydrate
- T10462L
- Bavisant dihydrochloride [USAN]
- Bavisant dihydrochloride monohydrate
Look up BAVISANT in the interactive SynDRA portal →